RE:RE:RE:RE:RE:RE:RE:RE:RE:The Way I see itOf course you benefit from CE marking, I'm not suggesting otherwise. But with IVDs, the main markets still require legitimate validation in the style of HC or FDA EUA. SONA has failed to achieve this to date.
Unfortunately from the outset the investors in this mess of a stock have been misled repeatedly, and continue to come back for more. Maybe SONA will achieve some sales, I hope they do in fact. But the window for this to be one of the big players has closed, mainly because of the BS Saudi clinical trial which looks highly questionable. Biden won't come calling, HC don't believe it works, and no major EU countries have even started to evaluate it yet.
Wake up FFS